Samotolisib [1386874-06-1]

TargetMol Chemicals

Samotolisib [1386874-06-1]

4

1386874-06-1

Chemical

Research Use Only

Samotolisib

99.71%

C23H26N4O3

406.48

Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.

3 years

COC(C)Cn1c2c(cnc3ccc(cc23)-c2cncc(c2)C(C)(C)O)n(C)c1=O

-20°C

12352200